ArticleClinical sarcoma research2019

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.

Nam Q Bui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.